UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Designing Fluoroquinolone Breakpoints for Streptococcus pneumoniae by Using Genetics instead of Pharmacokinetics-Pharmacodynamics

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3630-3635

2004

Volltextzugriff (PDF)

Synthesis and Characterization of Silver and Gold Nanoparticles Using Aqueous Extract of Seaweed, Turbinaria conoides, and Their Antimicrofouling Activity

TheScientificWorld, 2014-01, Vol.2014 (2014), p.1-10

2014

Volltextzugriff (PDF)

Pharmacodynamics of Moxifloxacin versus Vancomycin against Biofilms of Methicillin-Resistant Staphylococcus aureus and epidermidis in an In Vitro Model

Journal of chemotherapy (Florence), 2010-08, Vol.22 (4), p.238-242

2010

Volltextzugriff (PDF)

Microbiological Appraisal of Levofloxacin Activity Against Pseudomonas aeruginosa Biofilm in Combination with Different Calcium Channel Blockers In Vitro

Journal of chemotherapy (Florence), 2009-04, Vol.21 (2), p.135-143

2009

Volltextzugriff (PDF)

Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS

The Annals of pharmacotherapy, 1996-06, Vol.30 (6), p.612-614

1996

Volltextzugriff (PDF)

Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model

Journal of antimicrobial chemotherapy, 2011-06, Vol.66 (6), p.1301-1305

2011

Volltextzugriff (PDF)

Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study

Pharmacological research, 2001-02, Vol.43 (2), p.193-198

2001

Volltextzugriff (PDF)

Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin

American journal of clinical dermatology, 2008-01, Vol.9 (4), p.245-254

2008

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections

Current Opinion in Pharmacology, 2001-10, Vol.1 (5), p.459-463

2001

Volltextzugriff (PDF)

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

Journal of antimicrobial chemotherapy, 2012-07, Vol.67 (7), p.1706-1711

2012

Volltextzugriff (PDF)

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model

Journal of antimicrobial chemotherapy, 2009-08, Vol.64 (2), p.364-369

2009

Volltextzugriff (PDF)

Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model

Journal of antimicrobial chemotherapy, 2007-01, Vol.59 (1), p.144-147

2007

Volltextzugriff (PDF)

Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly

Drugs & aging, 2007-01, Vol.24 (4), p.275-292

2007

Volltextzugriff (PDF)

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum -lactamase-producing Escherichia coli using an in vitro model

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.643-646, Article 643

2008

Volltextzugriff (PDF)

Pharmacodynamic Modeling of Clarithromycin against Macrolide-Resistant [PCR-Positive mef(A) or erm(B)] Streptococcus pneumoniae Simulating Clinically Achievable Serum and Epithelial Lining Fluid Free-Drug Concentrations

Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.4029-4034

2002

Volltextzugriff (PDF)

Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium chanel blockers in vitro

Journal of chemotherapy (Florence), 2009-04, Vol.21 (2), p.135-143

2009

Volltextzugriff (PDF)

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae

International journal of antimicrobial agents, 2005-08, Vol.26 (2), p.120-125

2005

Volltextzugriff (PDF)

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy

Drug, healthcare and patient safety, 2011-01, Vol.3 (default), p.59-68

2011

Volltextzugriff (PDF)

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections

Treatments in respiratory medicine, 2006, Vol.5 (6), p.437-465

2006

Volltextzugriff (PDF)

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

International journal of antimicrobial agents, 2004-11, Vol.24 (5), p.479-484

2004

Volltextzugriff (PDF)

Pharmacodynamic Modeling of Clarithromycin against Macrolide-Resistant (PCR- Positive mef(A) or erm(B)) Streptococcus pneumoniae Simulating Clinically Achievable Serum and Epithelial Lining Fluid Free-Drug Concentrations

Antimicrobial agents and chemotherapy, 2002-12, Vol.46 (12), p.4029-4034

2002

Volltextzugriff (PDF)

Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models

The Annals of pharmacotherapy, 2003-09, Vol.37 (9), p.1331-1334

2003

Volltextzugriff (PDF)

Effects of Traditional Chinese Medicine Qinbai Qingfei Concentrated Pellet on Cellular Infectivity of Mycoplasma pneumoniae

International scholarly research notices, 2014, Vol.2014, p.751349-7

2014

Volltextzugriff (PDF)

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

Scientific reports, 2021-04, Vol.11 (1), p.8435-8435, Article 8435

2021

Volltextzugriff (PDF)

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens

Molecules (Basel, Switzerland), 2017-12, Vol.22 (12), p.2223

2017

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(84)
Buchkapitel
(2)

Sprache

Englisch
(85)
Französisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Designing Fluoroquinolone Breakpoints for Streptococcus pneumoniae by Using Genetics instead of Pharmacokinetics-Pharmacodynamics

Synthesis and Characterization of Silver and Gold Nanoparticles Using Aqueous Extract of Seaweed, Turbinaria conoides, and Their Antimicrofouling Activity

Pharmacodynamics of Moxifloxacin versus Vancomycin against Biofilms of Methicillin-Resistant Staphylococcus aureus and epidermidis in an In Vitro Model

Microbiological Appraisal of Levofloxacin Activity Against Pseudomonas aeruginosa Biofilm in Combination with Different Calcium Channel Blockers In Vitro

Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS

Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model

Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study

Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin

Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model

Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model

Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum -lactamase-producing Escherichia coli using an in vitro model

Pharmacodynamic Modeling of Clarithromycin against Macrolide-Resistant [PCR-Positive mef(A) or erm(B)] Streptococcus pneumoniae Simulating Clinically Achievable Serum and Epithelial Lining Fluid Free-Drug Concentrations

Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium chanel blockers in vitro

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

Pharmacodynamic Modeling of Clarithromycin against Macrolide-Resistant (PCR- Positive mef(A) or erm(B)) Streptococcus pneumoniae Simulating Clinically Achievable Serum and Epithelial Lining Fluid Free-Drug Concentrations

Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models

Effects of Traditional Chinese Medicine Qinbai Qingfei Concentrated Pellet on Cellular Infectivity of Mycoplasma pneumoniae

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens

Suchergebnisse filtern